These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Tacrine and lecithin in Alzheimer's disease. Serum tacrine concentrations too low. Roberts C; Mäkelä P; Ford J; Truman C BMJ; 1994 Jun; 308(6942):1506; author reply 1507. PubMed ID: 8019289 [No Abstract] [Full Text] [Related]
26. Tacrine and lecithin in Alzheimer's disease. Patient heterogeneity explains varied response. Levy R BMJ; 1994 Jun; 308(6942):1506; author reply 1507. PubMed ID: 8019288 [No Abstract] [Full Text] [Related]
27. Tacrine and lecithin in Alzheimer's disease. Negative conclusions not justified. Wilcock GK BMJ; 1994 Jun; 308(6942):1507. PubMed ID: 8019291 [No Abstract] [Full Text] [Related]
28. Pharmacoepidemiology of tacrine in Alzheimer's disease. Begaud B; Haramburu F; Miremont G Methods Find Exp Clin Pharmacol; 1996; 18 Suppl B():77-8. PubMed ID: 8899701 [No Abstract] [Full Text] [Related]
29. [Tacrine in the treatment of Alzheimer's disease]. Weinstein HC; Teunisse S; van Gool WA; van Crevel H Ned Tijdschr Geneeskd; 1991 Aug; 135(35):1575-7. PubMed ID: 1922487 [No Abstract] [Full Text] [Related]
30. Effect of tacrine in Alzheimer's disease: or non-effect? Broe GA; Creasey H Med J Aust; 1994 Sep; 161(6):348-9. PubMed ID: 8090107 [No Abstract] [Full Text] [Related]
32. Alternatives in the treatment of memory loss in patients with Alzheimer's disease. Volger BW Clin Pharm; 1991 Jun; 10(6):447-56. PubMed ID: 2065522 [TBL] [Abstract][Full Text] [Related]
33. Approaches to rational drug development in Alzheimer's disease. Iversen LL; Iversen SD; Freedman SB; Dawson G; Rupniak N; Hargreaves RJ; Showell GA; Street LJ; Baker R Drug Des Discov; 1993; 9(3-4):251-9. PubMed ID: 8400006 [No Abstract] [Full Text] [Related]
34. Tacrine for Alzheimer's disease. Med Lett Drugs Ther; 1993 Sep; 35(905):87-8. PubMed ID: 8361451 [No Abstract] [Full Text] [Related]
35. Intracranial drug administration in Alzheimer's disease. Harbaugh RE Psychopharmacol Bull; 1986; 22(1):106-9. PubMed ID: 3726055 [No Abstract] [Full Text] [Related]
36. Effect of tacrine in Alzheimer's disease: or non-effect? Talmont DM; Bowden M Med J Aust; 1995 Jan; 162(1):52-3. PubMed ID: 7710524 [No Abstract] [Full Text] [Related]
37. Pharmacologic approaches to cognitive deficits in Alzheimer's disease. Peskind ER J Clin Psychiatry; 1998; 59 Suppl 9():22-7. PubMed ID: 9720483 [TBL] [Abstract][Full Text] [Related]
38. Alzheimer's disease: the role of tacrine therapy. Jogerst G Iowa Med; 1995 Oct; 85(10):409-11. PubMed ID: 7591656 [No Abstract] [Full Text] [Related]
39. AF102B: rational treatment strategy for Alzheimer's disease: recent advances. Fisher A; Brandeis R; Karton I; Pittel Z; Dachir S; Sapir M; Grunfeld Y; Levy A; Heldman E Adv Neurol; 1990; 51():257-9. PubMed ID: 2403717 [No Abstract] [Full Text] [Related]